![Cancers | Free Full-Text | Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors Cancers | Free Full-Text | Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors](https://www.mdpi.com/cancers/cancers-15-02471/article_deploy/html/images/cancers-15-02471-g001.png)
Cancers | Free Full-Text | Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
![Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737217300269-gr1.jpg)
Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect
![Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer](https://www.cell.com/cms/attachment/436e6001-0579-4578-9f56-bf266bdf3b02/gr1_lrg.jpg)
Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer
![Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health](https://www.thelancet.com/cms/attachment/e977474a-6e1f-4500-b5df-bcde846c02df/gr1.gif)
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health
![Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.15.306/asset/images/medium/figure1.gif)
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology
![Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/776bf4a0-8421-4fe8-931d-e7f77e79a903/emmm201911416-abs-0001-m.jpg)
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine
![JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows](https://www.mdpi.com/jcm/jcm-11-04710/article_deploy/html/images/jcm-11-04710-g001.png)
JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
![Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management - ScienceDirect Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365916306083-fx1.jpg)
Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management - ScienceDirect
![Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | springermedizin.de Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | springermedizin.de](https://media.springernature.com/lw345/springer-static/image/art%3A10.1007%2Fs12663-023-01963-y/MediaObjects/12663_2023_1963_Figa_HTML.png?as=jpg)
Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour | springermedizin.de
![Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells](https://www.spandidos-publications.com/article_images/ijo/43/1/IJO-43-01-0271-g01.jpg)
Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells
![JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies](https://pub.mdpi-res.com/jcm/jcm-11-06254/article_deploy/html/images/jcm-11-06254-g001.png?1667892707)